CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project develops an advanced microfluidic tool for screening cancer cells, enhancing diagnosis and treatment selection. It utilizes innovative magnetic nanoparticles and automated systems for high-resolution imaging and molecular typing, aiming to improve cancer research and drug discovery.
The project aims at developing a new integrated and automated microfluidic tool for cancer cells screening.
This instrument will have a reliability and power much beyond state of the art (capture yield increased by a factor from 10X to 100X and multimodal typing of the cells in 3D high resolution images), allowing earlier and more accurate diagnosis, prognosis and selection of treatments of cancers.
CaMiNEMS’s new approach will involve a new generation of bio-functionalised multifunctional magne…
INSTITUT CURIE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Czechia, Pardubice
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
IMC ASCR INSTITUTE OF MACROMOLECULAR CHEMISTRY OF THE ASCR VVI
Czechia, Praha 6
Type: Research institute
Activity type: Research Organisations
SME: No
France, Le Kremlin-Bicetre
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
IPATIMUP - INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO PCUP
Portugal, Porto
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.